White to off- white coloured, circular biconvex shaped uncoated tablet debossed with H on one side and 01 on other side. Doxazosin is not appropriate for first-line treatment.
It may be used as a monotherapy in patients who have failed to respond to or have contraindications to other agents. Alternatively, daily should be limited to second or third line treatment in doxazosin mesylate with other antihypertensives. Doxazosin is used in a once daily regimen: Dosage may then be increased to 2mg after an additional one or two weeks of therapy and thereafter, if necessary to 4mg.
daily The doxazosin mesylate of patients who respond to Doxazosin will do so at a doxazosin mesylate of 4mg or less. Dosage can be further cartia xt vs diltiazem for afib if necessary to 8mg or the maximum recommended dose of 16mg. Depending on the individual patient's urodynamics and BPH symptomatology dosage may then be increased to 2mg and thereafter to 4mg and up to the maximum recommended dose of 8mg.
The recommended titration interval is weeks. The usual recommended dose is mg daily.
Sincethere is no change in pharmacokinetics in patients with impaired renal function, the usual adult dose of doxazosin is recommended. There are only limited data in patients with liver impairment and on the effect of drugs known to influence hepatic metabolism e.
As with any drug wholly metabolised by the liver, Doxazosin should be administered with caution to doxazosin mesylate 1 mg daily with evidence of impaired liver function see section 4.
Doxazosin is contraindicated as monotherapy in patients with either doxazosin mesylate 1 mg daily bladder or anuria with or without progressive renal insufficiency. In relation with the alpha-blocking doxazosin mesylate 1 mg daily of doxazosin, patients may experience postural hypotension evidenced please click for source dizziness and weakness, or rarely loss of consciousness syncopeparticularly with the commencement of therapy see section 4.
Daily, it is prudent medical practice to monitor blood pressure on initiation of therapy doxazosin mesylate minimise the potential for postural effects. When instituting therapy with any effective alpha-blocker, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop.
The patient doxazosin mesylate 1 mg daily be cautioned to avoid situations where injury could result, should dizziness or weakness occur during the initiation of daily therapy. As with any other vasodilatory anti-hypertensive agent it is prudent daily practice to advise caution when administering doxazosin to patients with the following acute cardiac conditions:.
As with any drug wholly metabolised by the liver, doxazosin should doxazosin mesylate 1 mg daily administered with daily caution to patients with evidence of impaired hepatic function see section 4.
Since there is no clinical experience in doxazosin mesylate with severe hepatic impairment use in these patients is not recommended. Concomitant administration of doxazosin with phosphodiesteraseinhibitors e. To reduce the risk of orthostatic hypotension it is recommended daily initiate the treatment with phosphodiesteraseinhibitors only if the patient is hemodynamically stabilized on alpha-blocker therapy.
Furthermore, daily is recommended to initiate phosphodiesteraseinhibitor treatment with the lowest possible dose and to respect a 6-hour daily interval from intake daily doxazosin. No studies have been conducted with doxazosin prolonged release formulations. The 'Intraoperative Floppy Iris Syndrome' IFIS, a variant of small pupil syndrome has been daily during cataract surgery in some patients on or previously treated with tamsulosin. Isolated reports have also been received with other alpha-1 blockers and daily possibility of a class effect doxazosin mesylate be excluded.
As IFIS may lead to increased procedural complications during the cataract operation current or past use of alpha-1 blockers should be made known to the ophthalmic surgeon in advance of surgery. Prolonged erections and priapism have been reported with alpha-1 blockers including doxazosin in post marketing experience. If priapism is not treated immediately, doxazosin mesylate 1 mg daily could result in penile tissue damage and permanent loss of potency, therefore the patient should seek immediate medical assistance.
Carcinoma of the prostate causes many of the symptoms associated with BPH and the two link daily co-exist.
Doxazosin mesylate of the prostate should therefore be ruled out prior to commencing therapy with doxazosin for treatment of BPH symptoms.
Patients with doxazosin mesylate hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Concomitant administration of doxazosin with a PDE-5 inhibitor may lead to symptomatic hypotension in some patients see section 4. In vitro data daily human plasma indicates daily doxazosin has no effect on protein binding of the drugs tested digoxin, phenytoinwarfarin or indomethacin.
Conventional doxazosin has been administered without any adverse drug interaction in clinical experience with thiazide diuretics, furosemide, beta-blocking agents, non-steroidal anti-inflammatory drugs, antibiotics, oral hypoglycaemic drugs, uricosuric agents, oranticoagulants. Doxazosin potentiates the blood pressure lowering activity of other alpha-blockers and other antihypertensives.
As there are daily adequate and well controlled studies in pregnant women, the safety of doxazosin during pregnancy has not yet been established. Accordingly, during pregnancy, doxazosin should be used only when, daily read article opinion of physician, the potential benefit outweighs the potential risk.
Although no teratogenic effects were seen doxazosin mesylate animal testing, reduced foetal survival was observed in animals at doxazosin mesylate 1 mg daily high doses see section 5.
2018 ©